Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boehringer ingelheim
7
×
boston blog main
7
×
boston top stories
life sciences
national blog main
biotech
national top stories
san francisco blog main
san francisco top stories
clinical trials
eli lilly
cancer
deals
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
wisconsin blog main
wisconsin top stories
abbvie
boston
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
hepatitis b
merck
moderna
pfizer
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
alexion pharmaceuticals
What
bio
companies
life
medicines
roundup
science
week
cancer
deal
debut
dicerna
drug
intended
ipo
moves
pharma
rna
abandoning
acquisitions
ago
arena’s
baggage
bets
biggest
black
blood
bounty
broader
build
buy
caught
causing
ceo
cig
comeback
comes
company
company’s
continue
corner
Language
unset
Current search:
" boehringer ingelheim "
×
" boston blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
6 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines